Pirkko Tamsen



Born 1959. Active in the company since 2020. PhD, Board Director of Alzecure and Örebro University Holding (BM). 30 years industry experience including CEO of several SME and CRO companies as well as experience from large pharmaceutical companies Astra and Kabi.
Shareholding: 195 500 shares.

Mark Beveridge



Born 1978. Active in the company since 2020. B. Com, GradDipCA. More than 15 years of experience in finance and accounting, VP Finance Moberg Pharma, advisor in accounting, insurance and auditing, primarily at Crowe Horwath and Visma Services. Independent consultant within financial control, transaction consultancy and implementation of business systems.
Shareholding: 30 144 shares.

Cindy Wong

Interim CMO


Born 1959. Active in the company since 2020. MD, PhD. CMO at Moberg Pharma. Extensive international experience in clinical development and registration of new products as VP and Head of Global Clinical Development at Merz Pharmaceuticals and CMO at Q-Med/Galderma, as well as senior positions at regulatory authorities in both Sweden and Australia. Board certified in internal medicine and clinical immunology.
Shareholding: 0 shares.